SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-23-110484
Filing Date
2023-10-20
Accepted
2023-10-20 16:15:05
Documents
1
Group Members
SAMSARA BIOCAPITAL GP, LLCSRINIVAS AKKARAJU

Document Format Files

Seq Description Document Type Size
1 SC 13D tm2328773d1_sc13d.htm SC 13D 103170
  Complete submission text file 0001104659-23-110484.txt   104776
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Subject) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-89552 | Film No.: 231337311
SIC: 2834 Pharmaceutical Preparations

Mailing Address 628 MIDDLEFIELD ROAD PALO ALTO CA 94301
Business Address 628 MIDDLEFIELD ROAD PALO ALTO CA 94301 (650) 285-4270
Samsara BioCapital, L.P. (Filed by) CIK: 0001699737 (see all company filings)

IRS No.: 813958301 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D